Efficacy of nitroglycerin vs labetalol in hypertensive emergency among patients with a history of coronary artery disease

doi:10.4330/wjc.v18.i2.115528

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 2

This Article

(41)

(35)

(0)

(1)

(1252)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Cardiol. Feb 26, 2026; 18(2): 115528
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.115528

Full Size Figure Download Figure

Figure 3 Crude and adjusted odds ratios for clinical outcomes. MACE: Major adverse cardiovascular event; OR: Odds ratio; CI: Confidence interval; MI: Myocardial infarction; HF: Heart failure; AKI: Acute kidney injury.

Citation: Chaudhary AJ, Bhat WA, Ul Haq A, Rashid HU, Khan ID, Khan MND, Nawaz HMM, Ali S, Tariq MH. Efficacy of nitroglycerin vs labetalol in hypertensive emergency among patients with a history of coronary artery disease. World J Cardiol 2026; 18(2): 115528
URL: https://www.wjgnet.com/1949-8462/full/v18/i2/115528.htm
DOI: https://dx.doi.org/10.4330/wjc.v18.i2.115528

Chaudhary AJ, Bhat WA, Ul Haq A, Rashid HU, Khan ID, Khan MND, Nawaz HMM, Ali S, Tariq MH. Efficacy of nitroglycerin vs labetalol in hypertensive emergency among patients with a history of coronary artery disease. World J Cardiol 2026; 18(2): 115528 [PMID: 41694034 DOI: 10.4330/wjc.v18.i2.115528]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.